Expression of MLL2/KMT2D was significantly upregulated in CML patients when compared to control samples (Fig. 1a, Mann–Whitney test, p < 0.0001). This evidence concerns the gene KMT2D and chronic myelogenous leukemia, BCR-ABL1 positive.